Literature DB >> 15370541

Rab escort protein 1 (REP1) in intracellular traffic: a functional and pathophysiological overview.

Markus Preising1, Carmen Ayuso.   

Abstract

The intracellular distribution of proteins, compartments, substrates, and products is an active process called intracellular traffic. Control of intracellular traffic is established by small GTP-binding proteins (Rab proteins). Rab proteins are modified by geranyl-geranyl moieties necessary for membrane association and target-protein recognition. Geranyl-geranyl groups are transferred to Rab proteins by geranyl-geranyl transferase 2 (GGTase2). GGTase2 requires Rab escort protein 1 (REP1) to bind Rab proteins. REP1 null mutations underlie an X-linked retinal degeneration called choroideremia (CHM). This review summarizes the current biochemical and clinical knowledge on REP1 and CHM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370541     DOI: 10.1080/13816810490514333

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  23 in total

1.  Visual Function at the Atrophic Border in Choroideremia Assessed with Adaptive Optics Microperimetry.

Authors:  William S Tuten; Grace K Vergilio; Gloria J Young; Jean Bennett; Albert M Maguire; Tomas S Aleman; David H Brainard; Jessica I W Morgan
Journal:  Ophthalmol Retina       Date:  2019-05-08

2.  Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study.

Authors:  Tomas S Aleman; Grace Han; Leona W Serrano; Nicole M Fuerst; Emily S Charlson; Denise J Pearson; Daniel C Chung; Anastasia Traband; Wei Pan; Gui-Shuang Ying; Jean Bennett; Albert M Maguire; Jessica I W Morgan
Journal:  Ophthalmology       Date:  2016-12-13       Impact factor: 12.079

3.  High-resolution images of retinal structure in patients with choroideremia.

Authors:  Reema Syed; Sanna M Sundquist; Kavitha Ratnam; Shiri Zayit-Soudry; Yuhua Zhang; J Brooks Crawford; Ian M MacDonald; Pooja Godara; Jungtae Rha; Joseph Carroll; Austin Roorda; Kimberly E Stepien; Jacque L Duncan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-01       Impact factor: 4.799

4.  Retinal nerve fiber thickness measurements in choroideremia patients with spectral-domain optical coherence tomography.

Authors:  Mohamed A Genead; J Jason McAnany; Gerald A Fishman
Journal:  Ophthalmic Genet       Date:  2011-01-26       Impact factor: 1.803

Review 5.  Clinical characteristics and current therapies for inherited retinal degenerations.

Authors:  José-Alain Sahel; Katia Marazova; Isabelle Audo
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-16       Impact factor: 6.915

6.  Loss-of-function mutations in Rab escort protein 1 (REP-1) affect intracellular transport in fibroblasts and monocytes of choroideremia patients.

Authors:  Natalia V Strunnikova; Jennifer Barb; Yuri V Sergeev; Ashwin Thiagarajasubramanian; Christopher Silvin; Peter J Munson; Ian M Macdonald
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

7.  Choroideremia: analysis of the retina from a female symptomatic carrier.

Authors:  Vera L Bonilha; Karmen M Trzupek; Yong Li; Peter J Francis; Joe G Hollyfield; Mary E Rayborn; Nizar Smaoui; Richard G Weleber
Journal:  Ophthalmic Genet       Date:  2008-09       Impact factor: 1.803

Review 8.  Choroideremia: new findings from ocular pathology and review of recent literature.

Authors:  Ian M MacDonald; Laurie Russell; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2009 May-Jun       Impact factor: 6.048

9.  Noncell-autonomous photoreceptor degeneration in a zebrafish model of choroideremia.

Authors:  Bryan L Krock; Joseph Bilotta; Brian D Perkins
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

10.  Silencing of the CHM gene alters phagocytic and secretory pathways in the retinal pigment epithelium.

Authors:  Nataliya V Gordiyenko; Robert N Fariss; Connie Zhi; Ian M MacDonald
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.